Healing the health divide
Despite government initiatives to support biopharma and med-tech research for women’s health products, companies ultimately need to seek private market funding for further development. Anna Zornosa-Heymann, a women’s health investor, works with the U.S. NIH’s SEED office to assist companies in transitioning from government funding to external sources. While government funds are valuable for research, they do not provide the necessary resources to create a top-notch team or establish a sales infrastructure, according to Zornosa-Heymann, as reported by BioWorld.